Status:

COMPLETED

Serum Procalcitonin Study in the Management of Ventilated Patients

Lead Sponsor:

University of Missouri-Columbia

Conditions:

Ventilator Associated Pneumonia

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amo...

Detailed Description

Ventilator-associated pneumonia is a leading cause of mortality in critically ill patients. The purpose of this study is to evaluate the relationship between the onset/progress/resolution of pneumonia...

Eligibility Criteria

Inclusion

  • Are willing to give or who's proxy is willing to consent to be a study subject
  • Are at least 18 years of age;
  • Who are mechanically ventilated surgical intensive care unit patients.

Exclusion

  • Participation in any investigational device or drug trial within 30 days prior to enrollment.

Key Trial Info

Start Date :

September 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2014

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT00726167

Start Date

September 1 2008

End Date

August 1 2014

Last Update

October 5 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Missouri

Columbia, Missouri, United States, 65212

Serum Procalcitonin Study in the Management of Ventilated Patients | DecenTrialz